Rank #1707VNDA

Vanda Pharmaceuticals Inc.

$6.10

1.16% (Daily)

Market Cap

$360.56M

Revenue

$216.10M

Rank by MCap

#1707

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Mihael H. Polymeropoulos M.D.

Headquarters

Washington, DC

Employees

533

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for p...